SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Idorsia Enrolls First Patients in US Study of Quviviq Daytime Effects

Idorsia says the first patients have entered a US study examining daytime effects of Quviviq.

Related stories